A Novel GLP-1 and FGF21 Fusion Protein for the Treatment of Non-alcoholic Steatohepatitis (NASH)

A Novel GLP-1 and FGF21 Fusion Protein for the Treatment of Non-alcoholic Steatohepatitis (NASH)

Purpose: The objective of this study was to develop and produce a novel fusion protein that combines GLP-1 (glucagon-like peptide-1) and FGF21 (fibroblast growth factor 21), with the aim of achieving synergistic pharmacological effects through the targeting of dual pathways, followed by validation o...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhipeng Zhang, Yanqin Ma, Cheng Xie, Yan He, Dong Wang, Huaien Song, Miao Yuan, Xiaomei Zhang
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2025-04-01
Series:Advanced Pharmaceutical Bulletin
Subjects:
glp-1
fgf21
nash
fusion protein
weight loss and fat reduction
Online Access:https://apb.tbzmed.ac.ir/PDF/apb-15-162.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items